{"title":"Preparation and in vitro Bactericidal and Fungicidal Efficiency of NanoSilver\/Methylcellulose Hydrogel","authors":"A. Panacek, M. Kilianova, R. Prucek, V. Husickova, R. Vecerova, M. Kolar, L. Kvitek, R. Zboril ","volume":90,"journal":"International Journal of Chemical and Molecular Engineering","pagesStart":493,"pagesEnd":499,"ISSN":"1307-6892","URL":"https:\/\/publications.waset.org\/pdf\/9998416","abstract":"
In this work we describe the preparation of NanoSilver\/methylcellulose hydrogel containing silver nanoparticles (NPs) for topical bactericidal applications. Highly concentrated dispersion of silver NPs as high as of 5g\/L of silver with diameter of 10nm was prepared by reduction of AgNO3<\/sub> via strong reducing agent NaBH4<\/sub>. Silver NPs were stabilized by addition of sodium polyacrylate in order to prevent their aggregation at such high concentration. This way synthesized silver NPs were subsequently incorporated into methylcellulose suspension at elevated temperature resulting in formation of NanoSilver\/methylcellulose hydrogel when temperature cooled down to laboratory conditions. In vitro<\/em> antibacterial activity assay proved high bactericidal and fungicidal efficiency of silver NPs alone in the form of dispersion as well as in the form of hydrogel against broad spectrum of bacteria and yeasts including highly multiresistant strains such as methicillin-resistant Staphylococcus aureus<\/em>. A very low concentrations of silver as low as 0.84mg\/L Ag in as-prepared dispersion gave antibacterial performance. NanoSilver\/methylcellulose hydrogel showed antibacterial action at the lowest used silver concentration equal to 25mg\/L. Such prepared NanoSilver\/methylcellulose hydrogel represent promising topical antimicrobial formulation for treatment of burns and wounds.<\/p>\r\n","references":"[1]\tC. M. Luna, P. Vujacich, M. S. Niederman, C. Vay, C. Gherardi, J. Matera, and E. C. Jolly, \"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia,\u201d Chest, vol. 111, no. 3, pp. 676\u2013685, Mar. 1997.\r\n[2]\tJ. Rello, A. Torres, M. Ricart, J. Valles, J. Gonzalez, A. Artigas, and R. Rodrigueroisin, \"Ventilator Associated Pneumonia by Staphylococcus-Aureus - Comparison of Methicillin-Resistant and Methicillin-Sensitive Episodes,\u201d Am. J. Resp. Crit. Care., vol. 150, no. 6, pp. 1545\u20131549, Dec. 1994.\r\n[3]\tJ. R. Morones, J. L. Elechiguerra, A. Camacho, K. Holt, J. B. Kouri, J. T. Ramirez, and M. J. Yacaman, \"The bactericidal effect of silver nanoparticles,\u201d Nanotechnology, vol. 16, no. 10, pp. 2346\u20132353, Oct. 2005.\r\n[4]\tI. Sondi, and B. Salopek-Sondi, \"Silver nanoparticles as antimicrobial agent: a case study on E-coli as a model for Gram-negative bacteria,\u201d J. Colloid Interf. Sci., vol. 275, no. pp. 177\u2013182, Jul. 2004.\r\n[5]\tL. Kvitek, A. Panacek, J. Soukupova, M. Kolar, R. Vecerova, R. Prucek, M. Holecova, and R. Zboril, \"Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs),\u201d J. Phys. Chem. C, vol. 112, no. 15, pp. 5825\u20135834. Apr. 2008.\r\n[6]\tG. A. Martinez-Castanon, N. Nino-Martinez, F. Martinez-Gutierrez, J. R. Martinez-Mendoza, and F. Ruiz, \"Synthesis and antibacterial activity of silver nanoparticles with different sizes,\u201d J. Nanopart. Res., vol. 10, no. 8, pp. 1343\u20131348, Dec. 2008.\r\n[7]\tA. Panacek, M. Kolar, R. Vecerova, R. Prucek, J. Soukupova, V. Krystof, P. Hamal, R. Zboril, and L. Kvitek, \"Antifungal activity of silver nanoparticles against Candida spp,\u201d Biomaterials, vol. 30, no. 31, pp. 6333\u20136340, Nov. 2009.\r\n[8]\tA. Panacek, L. Kvitek, R. Prucek, M. Kolar, R. Vecerova, N. Pizurova, V. K. Sharma, T. Nevecna, and R, Zboril, \"Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity,\u201d J. Phys. Chem. B, vol. 110, no. 33, pp. 16248\u201316253, Aug. 2006.\r\n[9]\tS. Shrivastava, T. Bera, A. Roy, G. Singh, P. Ramachandrarao, and D. Dash, \"Characterization of enhanced antibacterial effects of novel silver nanoparticles,\u201d Nanotechnology, vol. 18, no. 22, pp. 225103, Jun. 2007.\r\n[10]\tS. Krajewski, R. Prucek, A. Panacek, M. Avci-Adali, A. Nolte, A. Straub, R. Zboril, H. P. Wendel, and L. Kvitek, \"Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood,\u201d Acta Biomaterialia, vol. 9, no. 7, pp. 7460\u20137468, Jul. 2013.\r\n[11]\tW. R. Li, X. B. Xie, Q. S. Shi, S. S. Duan, Y. S. Ouyang, and Y. B. Chen, \"Antibacterial effect of silver nanoparticles on Staphylococcus aureus,\u201d Biometals, vol. 24, no. 1, pp. 135\u2013141, Feb. 2011.\r\n[12]\tW. R. Li, X. B. Xie, Q. S. Shi, H. Y. Zeng, Y. S. Ou-Yang, and Y. B. Chen, \"Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli,\u201d Appl. Microbiol. Biot., vol. 85, no. 4, pp. 1115\u20131122, Jan. 2010.\r\n[13]\tH. H. Lara, N. V. Ayala-Nunez, L. D. I. Turrent, and C. R. Padilla,\u201d Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria,\u201d World J. Microb. Biot., vol. 26, no. 4, pp. 615\u2013621, Apr. 2010.\r\n[14]\tC. N. Lok, C. M. Ho, R. Chen, Q. Y. He, W. Y. Yu, H. Z. Sun, P. K. H. Tam, J. F. Chiu, and C. M. Che, \"Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res., vol. 5, no. 4, pp. 916\u2013924, Apr. 2006.\r\n[15]\tO. Choi, and Z. Q. Hu, \"Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria,\u201d Environ. Sci. Technol., vol. 42, no. 12, pp. 4583\u201345888 Jun. 2008.\r\n[16]\tJ. S. Kim, E. Kuk, K. N. Yu, J. H. Kim, S. J. Park, H. J. Lee, S. H. Kim, Y. K. Park, Y. H. Park, C. Y. Hwang, Y. K. Kim, Y. S. Lee, D. H. Jeong, M. H. Cho, \"Antimicrobial effects of silver nanoparticles,\u201d Nanomed. Nanotechnol., vol. 3, no. 1, pp. 95\u2013101, Mar. 2007.\r\n[17]\tH. Y. Xu, Qu F, Xu H, Lai WH, Wang YA, Aguilar ZP, and H. Wei, \"Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on Escherichia coli O157:H7,\u201d Biometals, vol. 25, no. 1, pp. 45\u201353, Feb. 2012.\r\n[18]\tC. L. Fox, and S. M. Modak, S. M., \"Mechanism of action of silver sulfadiazine on burn wound infections,\u201d Antimicrob. Agents Chemother., vol. 5, no. 6, pp. 582\u2013588, 1974.\r\n[19]\tX. Chen, and H. J. Schluesener, \"Nanosilver: A nanoproduct in medical application,\u201d Toxicol. Lett., vol. 176, no. 1, pp. 1\u201312, Jan. 2008.\r\n[20]\thttp:\/\/www.silvermedicine.org\/medical-products-silver.html.\r\n[21]\tY. M. Mohan, T. Premkumar, K. Lee, and K. E. Geckeler, \"Fabrication of silver nanoparticles in hydrogel networks,\u201d Macromol. Rapid Commun., vol. 27, no. 16, pp. 1346\u20131354, Aug. 2006.\r\n[22]\tV. Thomas, M. Namdeo, Y. M. Mohan, S. K. Bajpai, M. Bajpai, \"Review on polymer, hydrogel and microgel metal nanocomposites: A facile nanotechnological approach,\u201d J. Macromol. Sci. A, vol. 45, no. 1, pp. 107\u2013119, 2008.\r\n[23]\tK. Varaprasad, K. M. Mohan, S. Ravindra, N. Narayana Reddy, K. Vimala, K. Monika, B. Sreedhar and K. Mohana Raju, \"Hydrogel\u2013Silver Nanoparticle Composites: A New Generation of Antimicrobials,\u201d J. Polymer. Sci., vol. 115, no. 2, pp. 1199\u20131207, Jan 2010.\r\n[24]\tJ. Jain, S. Arora, J. M. Rajwade, P. Omray, S. Khandelwal, and K. M. Paknikar, \"Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use,\u201d Mol. Pharm., vol. 6, no. 5, pp. 1388\u20131401, Sep.\u2013Oct. 2009\r\n[25]\tT. R. Thatiparti, A. Kano, A. Maruyama, and A. Takahara, \"Novel Silver-Loaded Semi-Interpenetrating Polymer Network Gel Films with Antibacterial Activity, J. Polymer Sci. A., vol. 47, no. 19, pp. 4950\u20134962, Oct. 2009.\r\n","publisher":"World Academy of Science, Engineering and Technology","index":"Open Science Index 90, 2014"}